Itrabene Dermis

Itraconazole, the active ingredient in Itrabene Dermis, is an azole antifungal presented as an oral formulation for systemic use. It treats a range of serious fungal infections in adults and children when prescribed by a qualified healthcare professional.

GNH USA supplies Itrabene Dermis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable global logistics. Our supply chain adheres to EU Good Manufacturing Practice standards and includes temperature‑controlled shipping where required.

Itraconazole is used to treat systemic fungal infections by targeting the causative organisms in several disease categories.

- Blastomycosis: treatment of systemic infection caused by Blastomyces dermatitidis. - Histoplasmosis: eradication of disseminated Histoplasma capsulatum infection. - Aspergillosis: management of invasive disease caused by Aspergillus species. - Dermatophytosis: oral therapy for extensive or refractory skin fungal infections. - Candidiasis (systemic): treatment of invasive candidal infections. - Sporotrichosis: therapy for disseminated Sporothrix infection.

Itraconazole may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Abdominal pain: intermittent discomfort in the upper abdomen. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - QT prolongation: potential cardiac arrhythmia risk.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor liver function: obtain baseline and periodic hepatic enzyme tests. - Avoid use in pregnancy: drug is classified as Category D due to fetal risk. - Use caution in heart failure: may exacerbate fluid retention. - Review concomitant medications: assess for potential interactions. - Adjust dose in hepatic impairment: consider reduced dosing or alternative therapy. - Store at ambient temperature: keep in the original pack, protect from moisture.

Itraconazole has notable interactions that require attention.

Major Interactions (Avoid): - Rifampin: induces metabolism, reducing itraconazole exposure. - St. John’s wort: strong enzyme inducer, markedly decreasing drug levels. - Carbamazepine: accelerates clearance, compromising efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: may increase anticoagulant effect, monitor INR. - Phenytoin: can alter plasma concentrations, adjust dosing as needed. - Calcium channel blockers (e.g., verapamil): may increase itraconazole levels, watch for toxicity.